Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | -4.59% | -7.14% | +24.03% |
May. 07 | Transcript : X4 Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | X4 Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.03% | 183M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- XFOR Stock
- News X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Submits NDA to FDA for Mavorixafor to Treat WHIM Syndrome